Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.49 |
| ▸ | GSTM2 | P28161 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30498938 | 1.00 | MEN1 (1.00) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL5797619 | 0.87 | MEN1 (0.77) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL21046089 | 0.86 | MEN1 (0.76) | MEN1KMT2AMAPTMAPK1POLB | |
| Pyridine SCHEMBL27445603 | 0.84 | MEN1 (0.70) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL5795803 | 0.84 | KMT2A (0.71) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL1722633 | 0.81 | MEN1 (0.68) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL15227431 | 0.80 | MEN1 (0.66) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL15227436 | 0.80 | MEN1 (0.66) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL13437361 | 0.80 | MEN1 (0.66) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL20374684 | 0.79 | MEN1 (0.66) | MEN1KMT2AMAPTALDH1A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003037866-A1 | ANTIRETROVIRAL PYRIDINE AND QUINOLINE DERIVATIVES | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2003-05-08 | — | — | WO | claimed |
| US-6498254-B1 | Antiretroviral compounds and compositions | UNIROYAL CHEMICAL COMPANY, INC. | 2002-12-24 | — | — | US | claimed |
| JP-6228099-A | — | — | None | — | — | JP | disclosed |
| JP-6228098-A | — | — | None | — | — | JP | disclosed |
| EP-4464699-A1 | PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | Lisen Therapeutics, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| US-20240360145-A1 | PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | LISEN THERAPEUTICS, INC. | 2024-10-31 | — | — | US | disclosed |
| CN-118084896-A | Benzopyran compounds | 正大天晴药业集团股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023134582-A1 | PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 上海立森印迹医药技术有限公司 | 2023-07-20 | — | — | WO | disclosed |
| CN-116444488-A | Pyrimidine-2, 4-diamine derivative and preparation method and application thereof | 上海立森印迹医药技术有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-20210380548-A1 | Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family | CTXT PTY LIMITED (AU) | 2021-12-09 | — | — | US | disclosed |
| EP-3676266-A1 | FUSED [1,2,4]THIADIAZINE DERIVATIVES WHICH ACT AS KAT INHIBITORS OF THE MYST FAMILY | Ctxt Pty Ltd (AU) | 2020-07-08 | — | — | EP | disclosed |
| US-5714436-A | PRE- AND POSTEMERGENCE HERBICIDES; RICE; CROPS; MONO- AND DICOTYLEDONS | HOECHST SCHERING AGREVO GMBH (DE) | 1998-02-03 | — | — | US | disclosed |
| US-5648496-A | AMINATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-07-15 | — | — | US | disclosed |
| EP-0715629-B1 | N-HETEROARYL-N'(PYRID-2-YL-SULPHONYL) UREAS, PROCESSES FOR THE MANUFACTURE THEREOF, USES THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | HOECHST SCHERING AGREVO GMBH (DE) | 1997-01-29 | — | — | EP | disclosed |
| EP-0735025-A1 | Process for producing aminonitropyridines | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-10-02 | — | — | EP | disclosed |
| EP-0715629-A1 | N-HETEROARYL-N'(PYRID-2-YL-SULPHONYL) UREAS, PROCESSES FOR THE MANUFACTURE THEREOF, USES THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | HOECHST SCHERING AGREVO GMBH (DE) | 1996-06-12 | — | — | EP | disclosed |
| WO-1995006049-A1 | N-HETEROARYL-N'(PYRID-2-YL-SULPHONYL) UREAS, PROCESSES FOR THE MANUFACTURE THEREOF, USES THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | HOECHST SCHERING AGREVO GMBH (DE) | 1995-03-02 | — | — | WO | disclosed |
| JP-H06228099-A | PRODUCTION OF THIOL-PROTECTING DERIVATIVE | SANKYO KAGAKU KK | 1994-08-16 | — | — | JP | disclosed |
| JP-H06228098-A | PRODUCTION OF 3-NITRO-2-PYRIDINESULFENYL CHLORIDE | SANKYO KAGAKU KK | 1994-08-16 | — | — | JP | disclosed |
| EP-0555770-A1 | N-Heteroaryl-N'-(pyrid-2-yl-sulfonyl)-ureas, process for their preparation, and their use as herbicides and plant growth regulators | Hoechst Schering AgrEvo GmbH (DE) | 1993-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380548-A1 | Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family | KAT5, KAT6A, KAT2A | MEN1 1280/4885KMT2A 86/4885MAPT 422/4885 |
| US-20240360145-A1 | PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | DPYD, TYMP, TYMS | MEN1 1205/4885KMT2A 2435/4885MAPT 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.